Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Metastatic cancer linked to worse outcomes of COVID-19

Key clinical point: Cancer type, stage, and recent treatment may affect outcomes of COVID-19 in cancer patients.

Major finding: Compared to patients without cancer, those with metastatic cancer had a higher risk of severe/critical COVID-19 symptoms (odds ratio, 5.97; P < .01), ICU admission (OR, 6.59; P < .01), invasive mechanical ventilation (OR, 55.42; P < .01), and death (OR, 5.58; P = .01).

Study details: Multicenter study of 105 cancer patients and 536 noncancer patients, all with COVID-19.

Disclosures: The study was supported by the National Natural Science Foundation of China, the Singapore Ministry of Health’s National Medical Research Council, the National Institutes of Health/National Heart, Lung, and Blood Institute, and the Xiu Research Fund. Dr. Cai said she has no conflicts of interest.